ASSET PURCHASE AND PRODUCT DEVELOPMENT AGREEMENT by and between COLLAGENEX PHARMACEUTICALS INC. and THOMAS SKOLD Dated as of August 19, 2004Asset Purchase and Product Development Agreement • November 9th, 2004 • Collagenex Pharmaceuticals Inc • Pharmaceutical preparations • Pennsylvania
This ASSET PURCHASE AND PRODUCT DEVELOPMENT AGREEMENT (the “Agreement”), dated as of August 19, 2004 (the “Effective Date”), is made by and between CollaGenex Pharmaceuticals Inc., a Delaware corporation having its principal office at 41 University Drive, Newtown, Pennsylvania, United States of America 18940 (“CollaGenex”), and Thomas Skold, a citizen and resident of Sweden of Bjorno Gard, S-761 41 Norrtalje, Sweden (“Skold”). CollaGenex and Skold are each sometimes referred to individually as a “Party” and together as the “Parties.”
ContractStock Option Agreement • November 9th, 2004 • Collagenex Pharmaceuticals Inc • Pharmaceutical preparations
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.
